{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T13:53:13Z","timestamp":1762005193048,"version":"3.37.3"},"reference-count":50,"publisher":"The Endocrine Society","issue":"4","license":[{"start":{"date-parts":[[2020,3,7]],"date-time":"2020-03-07T00:00:00Z","timestamp":1583539200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,4,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Context<\/jats:title>\n                  <jats:p>Pituitary hormonal deficiencies in patients with craniopharyngioma may impair their bone health.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Objective<\/jats:title>\n                  <jats:p>To investigate bone health in patients with craniopharyngioma.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Design<\/jats:title>\n                  <jats:p>Retrospective cross-sectional study.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Setting<\/jats:title>\n                  <jats:p>Dutch and Swedish referral centers.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Patients<\/jats:title>\n                  <jats:p>Patients with craniopharyngioma (n = 177) with available data on bone health after a median follow-up of 16 years (range, 1-62) were included (106 [60%] Dutch, 93 [53%] male, 84 [48%] childhood-onset disease).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Main outcome measures<\/jats:title>\n                  <jats:p>Fractures, dual X-ray absorptiometry-derived bone mineral density (BMD), and final height were evaluated. Low BMD was defined as T- or Z-score \u2264-1 and very low BMD as \u2264-2.5 or \u2264-2.0, respectively.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Fractures occurred in 31 patients (18%) and were more frequent in men than in women (26% vs. 8%, P = .002). Mean BMD was normal (Z-score total body 0.1 [range, -4.1 to 3.5]) but T- or Z-score \u2264-1 occurred in 47 (50%) patients and T-score \u2264-2.5 or Z-score \u2264-2.0 in 22 (24%) patients. Men received less often treatment for low BMD than women (7% vs. 18%, P = .02). Female sex (OR 0.3, P = .004) and surgery (odds ratio [OR], 0.2; P = .01) were both independent protective factors for fractures, whereas antiepileptic medication was a risk factor (OR, 3.6; P = .03), whereas T-score \u2264-2.5 or Z-score \u2264-2.0 was not (OR, 2.1; P = .21). Mean final height was normal and did not differ between men and women, or adulthood and childhood-onset patients.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Men with craniopharyngioma are at higher risk than women for fractures. In patients with craniopharyngioma, a very low BMD (T-score \u2264-2.5 or Z-score \u2264-2.0) seems not to be a good predictor for fracture risk.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1210\/clinem\/dgz279","type":"journal-article","created":{"date-parts":[[2020,3,7]],"date-time":"2020-03-07T14:33:24Z","timestamp":1583591604000},"page":"e1397-e1407","source":"Crossref","is-referenced-by-count":7,"title":["Fractures, Bone Mineral Density, and Final Height in Craniopharyngioma Patients with a Follow-up of 16 Years"],"prefix":"10.1210","volume":"105","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8818-6759","authenticated-orcid":false,"given":"Selveta S","family":"van Santen","sequence":"first","affiliation":[{"name":"Department of Medicine, Endocrinology; Erasmus Medical Center, GD Rotterdam, The Netherlands"},{"name":"Department of Paediatric Oncology\/Haematology, Erasmus MC \u2013 Sophia Children\u2019s Hospital, CN Rotterdam, The Netherlands"},{"name":"Princess M\u00e1xima Center for Paediatric Oncology, CS Utrecht, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel S","family":"Olsson","sequence":"additional","affiliation":[{"name":"Department of Medicine, Endocrinology; Sahlgrenska University Hospital, Gothenburg, Sweden"},{"name":"Department of Internal Medicine and Clinical Nutrition, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7760-879X","authenticated-orcid":false,"given":"Marry M","family":"van den Heuvel-Eibrink","sequence":"additional","affiliation":[{"name":"Department of Paediatric Oncology\/Haematology, Erasmus MC \u2013 Sophia Children\u2019s Hospital, CN Rotterdam, The Netherlands"},{"name":"Princess M\u00e1xima Center for Paediatric Oncology, CS Utrecht, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark","family":"Wijnen","sequence":"additional","affiliation":[{"name":"Department of Medicine, Endocrinology; Erasmus Medical Center, GD Rotterdam, The Netherlands"},{"name":"Department of Paediatric Oncology\/Haematology, Erasmus MC \u2013 Sophia Children\u2019s Hospital, CN Rotterdam, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Casper","family":"Hammarstrand","sequence":"additional","affiliation":[{"name":"Department of Medicine, Endocrinology; Sahlgrenska University Hospital, Gothenburg, Sweden"},{"name":"Department of Internal Medicine and Clinical Nutrition, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph A M J L","family":"Janssen","sequence":"additional","affiliation":[{"name":"Department of Medicine, Endocrinology; Erasmus Medical Center, GD Rotterdam, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gudmundur","family":"Johannsson","sequence":"additional","affiliation":[{"name":"Department of Medicine, Endocrinology; Sahlgrenska University Hospital, Gothenburg, Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aart J","family":"van der Lely","sequence":"additional","affiliation":[{"name":"Department of Medicine, Endocrinology; Erasmus Medical Center, GD Rotterdam, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sebastian J C M M","family":"Neggers","sequence":"additional","affiliation":[{"name":"Department of Medicine, Endocrinology; Erasmus Medical Center, GD Rotterdam, The Netherlands"},{"name":"Department of Paediatric Oncology\/Haematology, Erasmus MC \u2013 Sophia Children\u2019s Hospital, CN Rotterdam, The Netherlands"},{"name":"Princess M\u00e1xima Center for Paediatric Oncology, CS Utrecht, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"80","published-online":{"date-parts":[[2020,3,7]]},"reference":[{"issue":"2","key":"2021122210041913200_CIT0001","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1210\/jc.2014-3525","article-title":"Excess mortality and morbidity in patients with craniopharyngioma, especially in patients with childhood onset: a population-based study in Sweden","volume":"100","author":"Olsson","year":"2015","journal-title":"J Clin Endocrinol Metab."},{"issue":"1","key":"2021122210041913200_CIT0002","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1038\/s41572-019-0125-9","article-title":"Craniopharyngioma","volume":"5","author":"M\u00fcller","year":"2019","journal-title":"Nat Rev Dis Primers."},{"issue":"6","key":"2021122210041913200_CIT0003","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1530\/EJE-17-0044","article-title":"Very long-term sequelae of craniopharyngioma","volume":"176","author":"Wijnen","year":"2017","journal-title":"Eur J Endocrinol."},{"issue":"12","key":"2021122210041913200_CIT0004","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1136\/adc.67.12.1472","article-title":"Growth hormone deficiency during puberty reduces adult bone mineral density","volume":"67","author":"Hyer","year":"1992","journal-title":"Arch Dis Child."},{"issue":"6","key":"2021122210041913200_CIT0005","first-page":"1919","article-title":"Bone loss is correlated to the severity of growth hormone deficiency in adult patients with hypopituitarism","volume":"84","author":"Colao","year":"1999","journal-title":"J Clin Endocrinol Metab."},{"issue":"5","key":"2021122210041913200_CIT0006","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1200\/JCO.2014.56.7933","article-title":"Anterior hypopituitarism in adult survivors of childhood cancers treated with cranial radiotherapy: a report from the St Jude Lifetime Cohort study","volume":"33","author":"Chemaitilly","year":"2015","journal-title":"J Clin Oncol."},{"issue":"6","key":"2021122210041913200_CIT0007","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1210\/jc.2011-0179","article-title":"Evaluation and treatment of adult growth hormone deficiency: an Endocrine Society clinical practice guideline","volume":"96","author":"Molitch","year":"2011","journal-title":"J Clin Endocrinol Metab."},{"issue":"1","key":"2021122210041913200_CIT0008","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s12020-017-1440-0","article-title":"Effects of growth hormone therapy on bone density and fracture risk in age-related osteoporosis in the absence of growth hormone deficiency: a systematic review and meta-analysis","volume":"59","author":"Barake","year":"2018","journal-title":"Endocrine."},{"issue":"5","key":"2021122210041913200_CIT0009","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1530\/EJE-08-0874","article-title":"Inadequacies of glucocorticoid replacement and improvements by physiological circadian therapy","volume":"160","author":"Debono","year":"2009","journal-title":"Eur J Endocrinol."},{"issue":"1","key":"2021122210041913200_CIT0010","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1530\/EJE-17-0707","article-title":"Excess morbidity and mortality in patients with craniopharyngioma: a hospital-based retrospective cohort study","volume":"178","author":"Wijnen","year":"2018","journal-title":"Eur J Endocrinol."},{"issue":"1","key":"2021122210041913200_CIT0011","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1530\/EJE-11-0229","article-title":"Hypothalamic involvement and insufficient sex steroid supplementation are associated with low bone mineral density in women with childhood onset craniopharyngioma","volume":"165","author":"Holmer","year":"2011","journal-title":"Eur J Endocrinol."},{"issue":"1","key":"2021122210041913200_CIT0012","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1530\/eje.0.1380089","article-title":"Hyperphagia in children with craniopharyngioma is associated with hyperleptinaemia and a failure in the downregulation of appetite","volume":"138","author":"Roth","year":"1998","journal-title":"Eur J Endocrinol."},{"issue":"12","key":"2021122210041913200_CIT0013","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1055\/s-2007-979888","article-title":"Serum leptin levels following hypothalamic surgery","volume":"28","author":"Brabant","year":"1996","journal-title":"Horm Metab Res."},{"issue":"2","key":"2021122210041913200_CIT0014","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0092-8674(00)81558-5","article-title":"Leptin inhibits bone formation through a hypothalamic relay: a central control of bone mass","volume":"100","author":"Ducy","year":"2000","journal-title":"Cell."},{"issue":"9","key":"2021122210041913200_CIT0015","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1007\/s00415-003-0152-y","article-title":"Neurological diseases and accidental falls of the aged","volume":"250","author":"Syrj\u00e4l\u00e4","year":"2003","journal-title":"J Neurol."},{"issue":"1 Suppl","key":"2021122210041913200_CIT0016","doi-asserted-by":"crossref","first-page":"87S","DOI":"10.1016\/8756-3282(95)00384-3","article-title":"Prevention of falls in the elderly","volume":"18","author":"Myers","year":"1996","journal-title":"Bone."},{"issue":"4","key":"2021122210041913200_CIT0017","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1111\/j.1600-0404.2005.00399.x","article-title":"An analysis of lifetime fractures in women with epilepsy","volume":"111","author":"Koppel","year":"2005","journal-title":"Acta Neurol Scand."},{"issue":"2","key":"2021122210041913200_CIT0018","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1007\/s10067-018-4370-1","article-title":"Osteoporosis: a clinical and pharmacological update","volume":"38","author":"Vidal","year":"2019","journal-title":"Clin Rheumatol."},{"issue":"4","key":"2021122210041913200_CIT0019","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1530\/eje.1.01877","article-title":"The clinical, metabolic and endocrine features and the quality of life in adults with childhood-onset craniopharyngioma compared with adult-onset craniopharyngioma","volume":"152","author":"Kendall-Taylor","year":"2005","journal-title":"Eur J Endocrinol."},{"issue":"4","key":"2021122210041913200_CIT0020","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1530\/EJE-13-0280","article-title":"Clinical characteristics and effects of GH replacement therapy in adults with childhood-onset craniopharyngioma compared with those in adults with other causes of childhood-onset hypothalamic-pituitary dysfunction","volume":"169","author":"Yuen","year":"2013","journal-title":"Eur J Endocrinol."},{"issue":"2","key":"2021122210041913200_CIT0021","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1359\/jbmr.2001.16.2.398","article-title":"The influence of growth hormone deficiency, growth hormone replacement therapy, and other aspects of hypopituitarism on fracture rate and bone mineral density","volume":"16","author":"W\u00fcster","year":"2001","journal-title":"J Bone Miner Res."},{"issue":"12","key":"2021122210041913200_CIT0022","doi-asserted-by":"crossref","first-page":"945","DOI":"10.3109\/09513590.2012.683080","article-title":"The risk of osteopenia in premenopausal women with various sellar tumors","volume":"28","author":"Zhao","year":"2012","journal-title":"Gynecol Endocrinol."},{"issue":"6","key":"2021122210041913200_CIT0023","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1507\/endocrj.52.751","article-title":"High risk of osteopenia and bone derangement in postsurgical patients with craniopharyngiomas, pituitary adenomas and other parasellar lesions","volume":"52","author":"Okinaga","year":"2005","journal-title":"Endocr J."},{"issue":"3","key":"2021122210041913200_CIT0024","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1055\/s-2003-39789","article-title":"Volumetric bone mineral density in patients with childhood craniopharyngioma","volume":"111","author":"M\u00fcller","year":"2003","journal-title":"Exp Clin Endocrinol Diabetes."},{"issue":"2","key":"2021122210041913200_CIT0025","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1136\/adc.75.2.108","article-title":"Growth and endocrine sequelae of craniopharyngioma","volume":"75","author":"DeVile","year":"1996","journal-title":"Arch Dis Child."},{"issue":"4","key":"2021122210041913200_CIT0026","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/S0090-3019(96)00216-9","article-title":"A comparison of children with suprasellar germ cell tumors and craniopharyngiomas: final height, weight, endocrine, and visual sequelae after treatment","volume":"46","author":"Ono","year":"1996","journal-title":"Surg Neurol."},{"issue":"4","key":"2021122210041913200_CIT0027","first-page":"190","article-title":"Final height and craniofacial development after surgical resection of craniopharyngioma","volume":"17","author":"Jensen","year":"1997","journal-title":"J Craniofac Genet Dev Biol."},{"issue":"2","key":"2021122210041913200_CIT0028","first-page":"91","article-title":"Efficacy and safety of growth hormone treatment in children with prior craniopharyngioma: an analysis of the Pharmacia and Upjohn International Growth Database (KIGS) from 1988 to 1996","volume":"49","author":"Price","year":"1998","journal-title":"Horm Res."},{"issue":"5","key":"2021122210041913200_CIT0029","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1515\/JPEM.2003.16.5.703","article-title":"Craniopharyngioma: presentation and endocrine sequelae in 36 children","volume":"16","author":"de Vries","year":"2003","journal-title":"J Pediatr Endocrinol Metab."},{"issue":"7","key":"2021122210041913200_CIT0030","doi-asserted-by":"crossref","first-page":"3298","DOI":"10.1210\/jc.2003-031751","article-title":"Longitudinal study on growth and body mass index before and after diagnosis of childhood craniopharyngioma","volume":"89","author":"M\u00fcller","year":"2004","journal-title":"J Clin Endocrinol Metab."},{"issue":"4","key":"2021122210041913200_CIT0031","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1111\/j.1651-2227.1988.tb10705.x","article-title":"Children with craniopharyngioma. Early growth failure and rapid postoperative weight gain","volume":"77","author":"Sorva","year":"1988","journal-title":"Acta Paediatr Scand."},{"issue":"9","key":"2021122210041913200_CIT0032","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1055\/a-0641-5956","article-title":"Childhood craniopharyngioma: a 22-year challenging follow-up in a single center","volume":"50","author":"Tosta-Hernandez","year":"2018","journal-title":"Horm Metab Res."},{"issue":"6","key":"2021122210041913200_CIT0033","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.anpedi.2013.06.039","article-title":"Endocrinological outcome in children and adolescents survivors of central nervous system tumours after a 5 year follow-up","volume":"80","author":"G\u00fcemes Hidalgo","year":"2014","journal-title":"An Pediatr (Barc)."},{"issue":"2","key":"2021122210041913200_CIT0034","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1530\/EJE-19-0181","article-title":"Diagnosing metabolic syndrome in craniopharyngioma patients: body composition versus BMI","volume":"181","author":"van Santen","year":"2019","journal-title":"Eur J Endocrinol."},{"author":"van Santen","key":"2021122210041913200_CIT0035","article-title":"Supplemental tables of \u201cBone health and final height in craniopharyngioma patients with a follow-up of 16 years\u201d DANS 2020;1-6"},{"issue":"15","key":"2021122210041913200_CIT0036","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1001\/jama.288.15.1889","article-title":"Clinical use of bone densitometry: scientific review","volume":"288","author":"Cummings","year":"2002","journal-title":"JAMA."},{"key":"2021122210041913200_CIT0037"},{"issue":"7","key":"2021122210041913200_CIT0038","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1111\/j.1651-2227.2002.tb03322.x","article-title":"Swedish population-based longitudinal reference values from birth to 18 years of age for height, weight and head circumference","volume":"91","author":"Wikland","year":"2002","journal-title":"Acta Paediatr."},{"issue":"9","key":"2021122210041913200_CIT0039","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1111\/j.1651-2227.2012.02722.x","article-title":"Body size and lifestyle in an urban population entering adulthood: the \u2018Grow up Gothenburg\u2019 study","volume":"101","author":"Sj\u00f6berg","year":"2012","journal-title":"Acta Paediatr."},{"issue":"5","key":"2021122210041913200_CIT0040","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1080\/08035250600582822","article-title":"Growth from birth to age 19 for children in Sweden born in 1981: descriptive values","volume":"95","author":"Werner","year":"2006","journal-title":"Acta Paediatr."},{"issue":"6","key":"2021122210041913200_CIT0041","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1359\/JBMR.040134","article-title":"A meta-analysis of prior corticosteroid use and fracture risk","volume":"19","author":"Kanis","year":"2004","journal-title":"J Bone Miner Res."},{"issue":"4","key":"2021122210041913200_CIT0042","doi-asserted-by":"crossref","first-page":"1880","DOI":"10.1210\/jc.2015-4228","article-title":"Association between hyponatremia, osteoporosis, and fracture: a systematic review and meta-analysis","volume":"101","author":"Upala","year":"2016","journal-title":"J Clin Endocrinol Metab."},{"key":"2021122210041913200_CIT0043","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.maturitas.2016.12.009","article-title":"Gender differences in the incidence of and risk factors for hip fracture: a 16-year longitudinal study in a southern European population","volume":"97","author":"Lobo","year":"2017","journal-title":"Maturitas."},{"issue":"10","key":"2021122210041913200_CIT0044","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1007\/s00198-007-0345-9","article-title":"Corticosteroid-induced osteoporosis prevention: longitudinal practice patterns in The Netherlands 2001-2005","volume":"18","author":"Duyvendak","year":"2007","journal-title":"Osteoporos Int."},{"issue":"4","key":"2021122210041913200_CIT0045","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1111\/j.1365-2753.2009.01172.x","article-title":"Morbidity figures from general practice: sex differences in traumatology","volume":"16","author":"Lagro-Janssen","year":"2010","journal-title":"J Eval Clin Pract."},{"issue":"1","key":"2021122210041913200_CIT0046","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s00198-012-2074-y","article-title":"European guidance for the diagnosis and management of osteoporosis in postmenopausal women","volume":"24","author":"Kanis","year":"2013","journal-title":"Osteoporos Int."},{"issue":"1","key":"2021122210041913200_CIT0047","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.abb.2010.06.027","article-title":"Fat and bone","volume":"503","author":"Reid","year":"2010","journal-title":"Arch Biochem Biophys."},{"key":"2021122210041913200_CIT0048","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1111\/nyas.12842","article-title":"Imaging methods for analyzing body composition in human obesity and cardiometabolic disease","volume":"1353","author":"Seabolt","year":"2015","journal-title":"Ann N Y Acad Sci."},{"issue":"4","key":"2021122210041913200_CIT0049","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1038\/oby.2008.595","article-title":"Validation of DXA body composition estimates in obese men and women","volume":"17","author":"LaForgia","year":"2009","journal-title":"Obesity (Silver Spring)."},{"issue":"1","key":"2021122210041913200_CIT0050","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.jocd.2008.09.004","article-title":"iDXA, Prodigy, and DPXL dual-energy X-ray absorptiometry whole-body scans: a cross-calibration study","volume":"12","author":"Hull","year":"2009","journal-title":"J Clin Densitom."}],"container-title":["The Journal of Clinical Endocrinology &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jcem\/article-pdf\/105\/4\/e1397\/41863323\/jcem_105_4_e1397.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/article-pdf\/105\/4\/e1397\/41863323\/jcem_105_4_e1397.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,22]],"date-time":"2021-12-22T18:14:11Z","timestamp":1640196851000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/105\/4\/e1397\/5799129"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,7]]},"references-count":50,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2020,3,7]]},"published-print":{"date-parts":[[2020,4,1]]}},"URL":"https:\/\/doi.org\/10.1210\/clinem\/dgz279","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"type":"print","value":"0021-972X"},{"type":"electronic","value":"1945-7197"}],"subject":[],"published-other":{"date-parts":[[2020,4]]},"published":{"date-parts":[[2020,3,7]]}}}